Q&A: Harnessing the power of the immune system to combat cancer

Currently, monoclonal antibodies targeting immune checkpoint proteins are a mainstay of cancer therapy and cancer drug development.

Related Keywords

Australia ,United Kingdom ,Inmune Bio ,Inmune Bio Inc ,Nasdaq ,Digital Journal ,